roche group: Live & Latest News Updates : Vimarsana.com

"We fell here by chance, but the bet on Terrasa cannot be changed."

Involved tweet Involved e-mail On Sunday, April 28, Kern Pharma was born 25 years ago, after the Indukern Group bought the Roche Group's plant in

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

Group sales grew by 2%1 at constant exchange rates , driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there...

[Ad Hoc Announcement Pursuant To Art. 53 LR] Roche Sales Increase By 2% (CER) In First Quarter With Both Divisions Growing In High Single Digit Ex COV...

F. Hoffmann-La Roche Ltd: Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 | Company Announcement

Investegate announcements from BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

MAINZ, Germany, April 22, 2024 -- BioNTech SE will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and...

Nykode Therapeutics ASA: Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer

FDA Approves Genentech's Alecensa For ALK-positive Early-Stage Lung Cancer

FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung...

F. Hoffmann-La Roche Ltd: FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer